
Meena A. Chelliah
Examiner (ID: 16847)
| Most Active Art Unit | 2204 |
| Art Unit(s) | 3641, 1612, 2204, 2899 |
| Total Applications | 790 |
| Issued Applications | 755 |
| Pending Applications | 11 |
| Abandoned Applications | 24 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19187775
[patent_doc_number] => 20240166688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 18/385640
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18385640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/385640 | Use of peptide for inhibiting functions and expressions of multiple disease biomarkers | Oct 30, 2023 | Issued |
Array
(
[id] => 19032558
[patent_doc_number] => 20240082373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/339230
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339230
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339230 | COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY AND USES THEREOF | Jun 20, 2023 | Pending |
Array
(
[id] => 19049394
[patent_doc_number] => 20240091363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => A SENSITIZER- PEPTIDE CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 18/329523
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329523 | A SENSITIZER- PEPTIDE CONJUGATE | Jun 4, 2023 | Pending |
Array
(
[id] => 18806940
[patent_doc_number] => 20230381273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/298798
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298798
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/298798 | NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF | Apr 10, 2023 | Pending |
Array
(
[id] => 18806940
[patent_doc_number] => 20230381273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/298798
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298798
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/298798 | NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF | Apr 10, 2023 | Pending |
Array
(
[id] => 18647650
[patent_doc_number] => 20230293420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES
[patent_app_type] => utility
[patent_app_number] => 18/296032
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296032 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES | Apr 4, 2023 | Abandoned |
Array
(
[id] => 18647650
[patent_doc_number] => 20230293420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES
[patent_app_type] => utility
[patent_app_number] => 18/296032
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296032 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES | Apr 4, 2023 | Abandoned |
Array
(
[id] => 18647650
[patent_doc_number] => 20230293420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES
[patent_app_type] => utility
[patent_app_number] => 18/296032
[patent_app_country] => US
[patent_app_date] => 2023-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296032 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION, PEPTIDE AND USE IN THE REDUCTION AND ELIMINATION OF WRINKLES AND EXPRESSION LINES | Apr 4, 2023 | Abandoned |
Array
(
[id] => 18692563
[patent_doc_number] => 20230322861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SYNTHETIC PEPTIDES FOR DISSOLVING TAU INCLUSIONS
[patent_app_type] => utility
[patent_app_number] => 18/124252
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18124252
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/124252 | SYNTHETIC PEPTIDES FOR DISSOLVING TAU INCLUSIONS | Mar 20, 2023 | Pending |
Array
(
[id] => 18649421
[patent_doc_number] => 20230295231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa
[patent_app_type] => utility
[patent_app_number] => 18/178143
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/178143 | Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa | Mar 2, 2023 | Pending |
Array
(
[id] => 18649421
[patent_doc_number] => 20230295231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa
[patent_app_type] => utility
[patent_app_number] => 18/178143
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/178143 | Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa | Mar 2, 2023 | Pending |
Array
(
[id] => 18737972
[patent_doc_number] => 20230346874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/107640
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/107640 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | Feb 8, 2023 | Pending |
Array
(
[id] => 18582879
[patent_doc_number] => 20230265136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => USE OF CNPY3 PROTEIN AS TARGET FOR TREATING OF DENGUE FEVER
[patent_app_type] => utility
[patent_app_number] => 18/063499
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063499 | USE OF CNPY3 PROTEIN AS TARGET FOR TREATING OF DENGUE FEVER | Dec 7, 2022 | Pending |
Array
(
[id] => 18497408
[patent_doc_number] => 20230220038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => BRI2 BRICHOS DOMAIN FOR DELIVERY OF PROTEINS INTO CNS NEURONS
[patent_app_type] => utility
[patent_app_number] => 18/046138
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046138 | BRI2 BRICHOS DOMAIN FOR DELIVERY OF PROTEINS INTO CNS NEURONS | Oct 11, 2022 | Pending |
Array
(
[id] => 18179865
[patent_doc_number] => 20230040594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY
[patent_app_type] => utility
[patent_app_number] => 17/812138
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812138 | MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY | Jul 11, 2022 | Pending |
Array
(
[id] => 18179865
[patent_doc_number] => 20230040594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY
[patent_app_type] => utility
[patent_app_number] => 17/812138
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812138 | MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY | Jul 11, 2022 | Pending |
Array
(
[id] => 17881200
[patent_doc_number] => 20220296677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/747360
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747360 | PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF | May 17, 2022 | Pending |
Array
(
[id] => 20272000
[patent_doc_number] => 12441769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Polypeptide, photoresist composition including the same, and method of forming pattern using the same
[patent_app_type] => utility
[patent_app_number] => 17/741590
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3834
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741590 | Polypeptide, photoresist composition including the same, and method of forming pattern using the same | May 10, 2022 | Issued |
Array
(
[id] => 18003552
[patent_doc_number] => 20220362318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHOD FOR TREATMENT OF PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 17/662989
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662989 | METHOD FOR TREATMENT OF PSORIASIS | May 10, 2022 | Pending |
Array
(
[id] => 18003552
[patent_doc_number] => 20220362318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHOD FOR TREATMENT OF PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 17/662989
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662989 | METHOD FOR TREATMENT OF PSORIASIS | May 10, 2022 | Pending |